STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CooperCompanies Announces Release Date for Third Quarter 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

CooperCompanies (Nasdaq: COO) has announced the release date for its third quarter 2024 financial results. The company will report its earnings on Wednesday, August 28, 2024, at 4:15 PM ET. Following the release, CooperCompanies will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. Investors and analysts can participate in the call by dialing 800-715-9871 with the conference ID 7528310. Additionally, a simultaneous audio webcast will be available, with a replay accessible later at http://investor.coopercos.com. This announcement provides shareholders and interested parties with the opportunity to stay informed about CooperCompanies' financial performance and future outlook.

Loading...
Loading translation...

Positive

  • Timely disclosure of financial results, demonstrating transparency
  • Provision of multiple access options for investors (conference call and webcast)

Negative

  • None.

SAN RAMON, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report third quarter 2024 financial results on Wednesday, August 28, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 7528310. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com


FAQ

When will CooperCompanies (COO) release its Q3 2024 financial results?

CooperCompanies (COO) will release its third quarter 2024 financial results on Wednesday, August 28, 2024, at 4:15 PM ET.

How can investors participate in CooperCompanies' (COO) Q3 2024 earnings call?

Investors can participate in CooperCompanies' Q3 2024 earnings call by dialing 800-715-9871 and using the conference ID 7528310. The call is scheduled for 5:00 PM ET on August 28, 2024.

Is there a webcast available for CooperCompanies' (COO) Q3 2024 earnings call?

Yes, a simultaneous audio webcast of CooperCompanies' Q3 2024 earnings call will be available, with a replay accessible later at http://investor.coopercos.com.

What is the date and time of CooperCompanies' (COO) Q3 2024 earnings conference call?

CooperCompanies' Q3 2024 earnings conference call is scheduled for Wednesday, August 28, 2024, at 5:00 PM ET.
Cooper

NASDAQ:COO

COO Rankings

COO Latest News

COO Latest SEC Filings

COO Stock Data

15.00B
197.58M
0.61%
104.09%
3.31%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
SAN RAMON